Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Hospital Anxiety and Depression Scale.
- Who it may be relevant to
- Registry conditions: Malignant Tumor, Anxiety, Depression. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Single-center, Real-world Prospective Observational Study of the Incidence and Development of Anxiety and Depression in Patients With Malignant Tumors
Overview
This study was a single-center prospective, real-world observational study with plans to enroll all eligible patients. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.
Detailed description
A total of 200 patients with malignant tumors will be enrolled in Henan Cancer Hospital. This study is a single-center prospective real-world observational study, and all eligible patients are planned to be enrolled. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.
Interventions
- Other Hospital Anxiety and Depression Scale
The basic information, anxiety and depression, treatment and prognosis of these patients were collected.
Primary outcome measures
- Hospital Anxiety Depression Scale [Time frame: Confirmed in 1 day]
- Hospital Anxiety Depression Scale [Time frame: End of the treatment]
- Hospital Anxiety Depression Scale [Time frame: The treatment ended 3 months later]
- Hospital Anxiety Depression Scale [Time frame: The treatment ended 6 months later]
- Hospital Anxiety Depression Scale [Time frame: The treatment ended one year later]
- Hospital Anxiety Depression Scale [Time frame: The treatment ended 2 years ago]
Eligibility criteria
Inclusion criteria
- Men and women of all ages are welcome.
- Pathological diagnosis of malignant tumor in our hospital.
- Received at least one hospitalization at this hospital.
- The expected survival time is greater than 1 year.
Exclusion criteria
1.There was no pathological report of malignancy.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-control
Study locations
China · 1 center
- Department of Bone and Soft Tissue ,Henan Cancer Hospital — Zhengzhou
Identifiers
NCT: NCT05596344 · ZZUSC-16